Want to create an interactive transcript for this episode?
Podcast: CME
Episode: Immunotherapy: Changing Patient Outcomes in SCLC
Description:
Host: Leora Horn, MD, MSc
Please note: This activity is no longer available for continuing education credit. Extensive-stage small cell lung cancer (ES-SCLC) is an aggressive disease with a poor prognosis. The recent addition of immunotherapy to the treatment landscape has changed the standard of care for ES-SCLC. In this interactive activity an expert will guide you through the latest evidence on checkpoint inhibitors for the management of ES-SCLC and offer expert insight into effectively and safely incorporating immunotherapy into your practice to improve patient outcomes.